| 1 |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动: 目前的认识和治疗建议(2021) [J]. 中华心律失常学杂志, 2022, 26(1): 15-88.
|
| 2 |
Shi S, Tang Y, Zhao Q, et al. Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study [J]. Lancet Reg Health West Pac, 2022, 23: 100439.
|
| 3 |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease [J]. Eur Heart J, 2022, 43(7): 561-632.
|
| 4 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018 [J]. 中华神经科杂志, 2018, 51(9): 666-682.
|
| 5 |
《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2020》概要 [J]. 中国脑血管病杂志, 2022, 19(2): 136-144.
|
| 6 |
马丽媛, 王增武, 樊静, 等. 《中国心血管健康与疾病报告2021》概要 [J]. 中国介入心脏病学杂志, 2022, 30(7): 481-496.
|
| 7 |
Spence JD. Cardioembolic stroke: everything has changed [J]. Stroke Vasc Neurol, 2018, 3(2): 76-83.
|
| 8 |
Kamel H, Healey JS. Cardioembolic stroke [J]. Circ Res, 2017, 120(3): 514-526.
|
| 9 |
Hu Y, Ji C. Efficacy and safety of thrombolysis for acute ischemic stroke with atrial fibrillation: a meta-analysis [J]. BMC Neurol, 2021, 21(1): 66.
|
| 10 |
Diener HC, Easton JD, Hart RG, et al. Review and update of the concept of embolic stroke of undetermined source [J]. Nat Rev Neurol, 2022, 18(8): 455-465.
|
| 11 |
Weir NU. An update on cardioembolic stroke [J]. Postgrad Med J, 2008, 84(989): 133-140.
|
| 12 |
Arboix A, Oliveres M, Massons J, et al. Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis [J]. Eur J Neurol, 1999, 6(6): 677-683.
|
| 13 |
Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study [J]. Stroke, 1996, 27(10): 1760-1764.
|
| 14 |
Bjerkreim AT, Khanevski AN, Thomassen L, et al. Five-year readmission and mortality differ by ischemic stroke subtype [J]. J Neurol Sci, 2019, 403: 31-37.
|
| 15 |
Escudero-Martinez I, Mazya M, Teutsch C, et al. Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry [J]. BMJ Open, 2020, 10(5): e037234.
|
| 16 |
Ma H, Che R, Zhang Q, et al. The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke: a real-world study [J]. J Neurol, 2023, 270(4): 2084-2095.
|
| 17 |
Paciaroni M, Agnelli G, Falocci N, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study [J]. Stroke, 2015, 46(8): 2175-2182.
|
| 18 |
Paciaroni M, Agnelli G, Falocci N, et al. Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study [J]. J Neurol, 2016, 263(2): 231-237.
|
| 19 |
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke [J]. N Engl J Med, 1995, 333(24): 1581-1587.
|
| 20 |
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J]. N Engl J Med, 2008, 359(13): 1317-1329.
|
| 21 |
Vaclavik D, Vilionskis A, Jatuzis D, et al. Clinical outcome of cardioembolic stroke treated by intravenous thrombolysis [J]. Acta Neurol Scand, 2018, 137(3): 347-355.
|
| 22 |
Padjen V, Jovanovic D, Berisavac I, et al. Effect of intravenous thrombolysis on stroke associated with atrial fibrillation [J]. J Stroke Cerebrovasc Dis, 2014, 23(8): 2199-2205.
|
| 23 |
Yamaji K, Fujimoto S, Yutani C, et al. Is the site of thrombus formation in the left atrial appendage associated with the risk of cerebral embolism? [J]. Cardiology, 2002, 97(2): 104-110.
|
| 24 |
Fan Y, Liao X, Pan Y, et al. Intravenous thrombolysis is safe and effective for the cryptogenic stroke in china: data from the thrombolysis implementation and monitor of acute ischemic stroke in China (TIMS-China) [J]. J Stroke Cerebrovasc Dis, 2019, 28(1): 220-226.
|
| 25 |
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [J]. Stroke, 2018, 49(3): e46-e110.
|
| 26 |
Kim BJ, Sohn H, Sun BJ, et al. Imaging characteristics of ischemic strokes related to patent foramen ovale [J]. Stroke, 2013, 44(12): 3350-3356.
|
| 27 |
Yang W, Kang DW, Kim JM, et al. Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke [J]. Sci Rep, 2022, 12(1): 11686.
|
| 28 |
Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis [J]. Curr Cardiol Rev, 2010, 6(3): 150-161.
|
| 29 |
Tiedt S, Herzberg M, Küpper C, et al. Stroke etiology modifies the effect of endovascular treatment in acute stroke [J]. Stroke, 2020, 51(3): 1014-1016.
|
| 30 |
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke [J]. N Engl J Med, 2015, 372(11): 1019-1030.
|
| 31 |
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke [J]. N Engl J Med, 2015, 372(24): 2296-2306.
|
| 32 |
NNogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct [J]. N Engl J Med, 2018, 378(1): 11-21.
|
| 33 |
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging [J]. N Engl J Med, 2018, 378(8): 708-718.
|
| 34 |
Matusevicius M, Cooray C, Rand VM, et al. Stroke etiology and outcomes after endovascular thrombectomy: results from the SITS registry and a meta-analysis [J]. J Stroke, 2021, 23(3): 388-400.
|
| 35 |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性卒中早期血管内介入诊疗指南2022 [J]. 中华神经科杂志, 2022, 55(6): 565-580.
|
| 36 |
Counsell C, Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke [J]. Cochrane Database Syst Rev, 2001(4): CD000119.
|
| 37 |
Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks [J]. Cochrane Database Syst Rev, 2007(3): CD006186.
|
| 38 |
梁景南. 华法林您用对了吗 [J]. 家庭医学, 2023(20): 55.
|
| 39 |
Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials [J]. Lancet, 2014, 383(9921): 955-962.
|
| 40 |
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation [J]. N Engl J Med, 2011, 365(11): 981-992.
|
| 41 |
Cairns JA. Stroke prevention in atrial fibrillation trial [J]. Circulation, 1991, 84(2): 933-935.
|
| 42 |
Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 [J]. N Engl J Med, 2007, 356(23): 2388-2398.
|
| 43 |
Saxena R, Koudstaal P. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack [J]. Cochrane Database Syst Rev, 2004(4): CD000187.
|
| 44 |
Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack [J]. Cochrane Database Syst Rev, 2004(2): CD000185.
|
| 45 |
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J]. Ann Intern Med, 2007, 146(12): 857-867.
|
| 46 |
Seiffge DJ, Paciaroni M, Wilson D, et al. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation [J]. Ann Neurol, 2019, 85(6): 823-834.
|
| 47 |
Smythe MA, Parker D, Garwood CL, et al. Timing of initiation of oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation [J]. Pharmacotherapy, 2020, 40(1): 55-71.
|
| 48 |
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC [J]. Eur Heart J, 2021, 42(5): 373-498.
|
| 49 |
Kimura S, Toyoda K, Yoshimura S, et al. Practical "1-2-3-4-day" rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study [J]. Stroke, 2022, 53(5): 1540-1549.
|
| 50 |
Oldgren J, Åsberg S, Hijazi Z, et al. Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study [J]. Circulation, 2022, 146(14): 1056-1066.
|
| 51 |
Fischer U, Koga M, Strbian D, et al. Early versus later anticoagulation for stroke with atrial fibrillation [J]. N Engl J Med, 2023, 388(26): 2411-2421.
|
| 52 |
Mac Grory B, Flood S, Schrag M, et al. Anticoagulation resumption after stroke from atrial fibrillation [J]. Curr Atheroscler Rep, 2019, 21(8): 29.
|